{"id":"W4285261941","doi":"10.1177/20363613221100033","title":"Quality of life of patients with soft tissue sarcoma treated with doxorubicin in the ANNOUNCE phase III clinical trial","year":2022,"lang":"en","type":"article","venue":"Rare Tumors","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Eli Lilly and Company","keywords":"Medicine; Soft tissue sarcoma; Doxorubicin; Clinical trial; Soft tissue; Quality of life (healthcare); Sarcoma; Phases of clinical research; Internal medicine; Oncology; Surgery; Pathology; Chemotherapy; Nursing","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007193474,0.0001584598,0.0007396953,0.00008329196,0.00005918911,0.000004281487,0.0001477488,0.00002967155,0.0001561258],"category_scores_gemma":[0.000177697,0.00008564583,0.00009084036,0.0004344101,0.0001394287,0.00003443646,0.00004061123,0.0002044402,0.000001323465],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005880982,"about_ca_system_score_gemma":0.0002062893,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006755854,"about_ca_topic_score_gemma":0.00009123706,"domain_scores_codex":[0.9975885,0.0004934877,0.0008021602,0.0002660858,0.0006686333,0.0001811889],"domain_scores_gemma":[0.9984139,0.0005365978,0.0004100764,0.0004525992,0.0001020337,0.00008479798],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0985038,0.01311713,0.8823351,0.00003476903,0.0001198108,0.0001742918,0.0006576012,0.00001114869,0.00001314066,0.00004417877,0.0004537766,0.004535282],"study_design_scores_gemma":[0.1988842,0.0139119,0.7849016,0.00006480356,0.000129969,0.000008001546,0.001109148,0.000008794696,0.0002219599,0.000007846877,0.0006474155,0.0001043519],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9974969,0.0001737259,0.000004110741,0.0003316876,0.00003512154,0.001572049,0.0001760864,0.00001556184,0.0001947528],"genre_scores_gemma":[0.9991534,0.000005188203,0.0000769754,0.000283737,0.00003805139,0.000177419,0.0002222111,0.00001592253,0.0000270456],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1003804,"threshold_uncertainty_score":0.3492535,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05644244604112402,"score_gpt":0.3660293904129465,"score_spread":0.3095869443718224,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}